No abstract available
Keywords:
cardiovascular system; hypertension; product labeling; renal denervation; risk assessment.
MeSH terms
-
Antihypertensive Agents / therapeutic use
-
Blood Pressure* / drug effects
-
Catheter Ablation* / adverse effects
-
Catheter Ablation* / trends
-
Clinical Trials as Topic
-
Drug Resistance
-
Forecasting
-
Humans
-
Hypertension / diagnosis
-
Hypertension / physiopathology
-
Hypertension / surgery*
-
Kidney / blood supply*
-
Renal Artery / innervation*
-
Sympathectomy / adverse effects
-
Sympathectomy / methods*
-
Sympathectomy / trends
-
Treatment Outcome